Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 56339 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 82386 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 95495 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 151683 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 158794 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 200027 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 226628 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 262255 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 302100 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 519891 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 793276 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 795705 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 830606 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 1421896 | Peak area normalized | female | normoglycemic | Neuropathy |